Indication

Renal cell carcinoma

Renal cell carcinoma is a primary malignant neoplasm of the urinary system that originates from the epithelial lining of the renal tubules and accounts for the vast majority of adult kidney cancers. Read more about Renal cell carcinoma

45 drugs 31 manufacturers

Advertisement

Drugs that treat it

Common Renal cell carcinoma therapies.

Showing 37–45 of 45 drugs

TEMSIROLIMUS

ANTINEOPLASTIC - MTOR KINASE INHIBITORS·RENAL CELL CARCINOMA
ALMAJECT, INC

PAZOPANIB HCL

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·SOFT OR CONNECTIVE TISSUE SARCOMA·+1
NOVUGEN PHARMA

SUNITINIB MALATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+3
NOVUGEN PHARMA

SUNITINIB MALATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+3
TEVA USA

TEMSIROLIMUS

ANTINEOPLASTIC - MTOR KINASE INHIBITORS·RENAL CELL CARCINOMA
FRESENIUS KABI

SUNITINIB MALATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+3
NOVADOZ PHARMAC

VOTRIENT (pazopanib HCl)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·SOFT OR CONNECTIVE TISSUE SARCOMA·+1
Novartis Pharmaceuticals
Filter & compare in the drug finder →Opens the drug finder with Renal cell carcinoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Renal cell carcinoma.

Renal cell carcinoma is a primary malignant neoplasm of the urinary system that originates from the epithelial lining of the renal tubules and accounts for the vast majority of adult kidney cancers.

Primarily affecting older adults with a male predominance, the disease encompasses several histologic subtypes, most commonly clear cell renal cell carcinoma, which is frequently driven by alterations in the von Hippel–Lindau tumor suppressor pathway and increased tumor vascularity.

Although many cases are detected incidentally on abdominal imaging, clinical manifestations can include hematuria, flank pain, a palpable abdominal mass, fatigue, unexplained weight loss, and various paraneoplastic syndromes.

Personalize your experience

Follow Renal cell carcinoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it